Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Marchetti

Showing results (31-40 of 128) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Investigation|October 20, 2007
Survival prediction of stage I lung adenocarcinomas by expression of 10 genesFabrizio Bianchi, Paolo Nuciforo, Manuela Vecchi, et al.
Pathologica|June 14, 2023
The ideal reporting of <i>RAS</i> testing in colorectal adenocarcinoma: a pathologists' perspectiveUmberto Malapelle, Valentina Angerilli, Francesco Pepe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 27, 2016
ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing AlgorithmAntonio Marchetti, Alessia Di Lorito, Maria Vittoria Pace, et al.
Plos One|January 5, 2012
KRAS mutations testing in colorectal carcinoma patients in Italy: from guidelines to external quality assessmentNicola Normanno, Carmine Pinto, Francesca Castiglione, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomasMattia Barbareschi, Fiamma Buttitta, Lara Felicioni, et al.
The American Journal of Pathology|February 17, 2009
Identification of potential therapeutic targets in malignant mesothelioma using cell-cycle gene expression analysisSolange Romagnoli, Ester Fasoli, Valentina Vaira, et al.
The Journal of Pathology|December 15, 2005
PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinomaFiamma Buttitta, Lara Felicioni, Fabio Barassi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinomaFiamma Buttitta, Caterina Pellegrini, Antonio Marchetti, et al.
Pathologica|February 15, 2023
Full cost of diagnostic pathology for lung carcinoma in Italy: results from four Pathology UnitsCarlo Lazzaro, Giovanni Fattore, Massimo Barberis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2014
Phase II study of afatinib, an irreversible ErbB family blocker, in EGFR FISH-positive non-small-cell lung cancerFederico Cappuzzo, Giovanna Finocchiaro, Francesco Grossi, et al.
Pageof 13

Showing results (31-40 of 128) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Investigation|October 20, 2007
Survival prediction of stage I lung adenocarcinomas by expression of 10 genesFabrizio Bianchi, Paolo Nuciforo, Manuela Vecchi, et al.
Pathologica|June 14, 2023
The ideal reporting of <i>RAS</i> testing in colorectal adenocarcinoma: a pathologists' perspectiveUmberto Malapelle, Valentina Angerilli, Francesco Pepe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 27, 2016
ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing AlgorithmAntonio Marchetti, Alessia Di Lorito, Maria Vittoria Pace, et al.
Plos One|January 5, 2012
KRAS mutations testing in colorectal carcinoma patients in Italy: from guidelines to external quality assessmentNicola Normanno, Carmine Pinto, Francesca Castiglione, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomasMattia Barbareschi, Fiamma Buttitta, Lara Felicioni, et al.
The American Journal of Pathology|February 17, 2009
Identification of potential therapeutic targets in malignant mesothelioma using cell-cycle gene expression analysisSolange Romagnoli, Ester Fasoli, Valentina Vaira, et al.
The Journal of Pathology|December 15, 2005
PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinomaFiamma Buttitta, Lara Felicioni, Fabio Barassi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinomaFiamma Buttitta, Caterina Pellegrini, Antonio Marchetti, et al.
Pathologica|February 15, 2023
Full cost of diagnostic pathology for lung carcinoma in Italy: results from four Pathology UnitsCarlo Lazzaro, Giovanni Fattore, Massimo Barberis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2014
Phase II study of afatinib, an irreversible ErbB family blocker, in EGFR FISH-positive non-small-cell lung cancerFederico Cappuzzo, Giovanna Finocchiaro, Francesco Grossi, et al.
Pageof 13